Stem cell-derived extracellular vesicle therapy for acute brain insults and neurodegenerative diseases
BMB Reports2022Vol. 55(1), pp. 20–29
Citations Over TimeTop 10% of 2022 papers
Abstract
Other SectionsABSTRACTINTRODUCTIONADVANTAGES OF STEM CELL-DERIVED EXTRACELLULAR VESICLES OVER OTHER THERAPEUTIC STRATEGIESAPPLICATIONS OF EXTRACELLULAR VESICLES IN BRAIN DISEASESLIMITATIONS OF CURRENT MSC-EV THERAPEUTICSENHANCING THE EFFICACY OF THERAPEUTIC EXTRACELLULAR VESICLESCLINICAL SCALE PRODUCTION OF EXTRACELLULAR VESICLESCONCLUSIONSACKNOWLEDGEMENTSCONFLICTS OF INTERESTFIGURESTABLEREFERENCES
Related Papers
- → Extracellular vesicle‐mediated delivery of circDYM alleviates CUS‐induced depressive‐like behaviours(2022)140 cited
- → MIBlood‐EV: Minimal information to enhance the quality and reproducibility of blood extracellular vesicle research(2023)115 cited
- → Extracellular vesicle-derived microRNA biomarkers: goals and pitfalls(2020)1 cited
- → [RETRACTED] Methods for HIV Promotes Atherosclerosis via Circulating Extracellular Vesicle microRNAs v1(2021)
- → Ultrasensitive and High‐Resolution Protein Spatially Decoding Framework for Tumor Extracellular Vesicles (Adv. Sci. 3/2024)(2024)